Get Premium to unlock powerful stock data
STU:ILU (USA)  
Illumina Inc logo

Illumina Inc

€ 183.64 (+5.5%) Jun 24
P/E:
42.16
P/B:
2.80
Market Cap:
€ 28.96B ($ 30.58B)
Enterprise V:
€ 30.10B ($ 31.78B)
Volume:
61.00
Avg Vol (2M):
20.00
Also Trade In:
Volume:
61.00
Market Cap €:
28.96B
Market Cap $:
30.58B
PE Ratio:
42.16
Avg Vol (2-Month):
20.00
Enterprise Value €:
30.10B
Enterprise Value $:
31.78B
PB Ratio:
2.80
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Financials (Next Earnings Date:2022-08-05 Est.)

STU:ILU's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4,047.979
EPS (TTM) (€) 3.941
Beta 0.65
Volatility % 39.22
14-Day RSI 35.38
14-Day ATR (€) 7.2381
20-Day SMA (€) 201.715
12-1 Month Momentum % -43.27
52-Week Range (€) 170.74 - 447.1
Shares Outstanding (Mil) 157.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Illumina Inc Filings

Document Form Filing Date
No Filing Data